Inspira Technologies OxyIINN
About: Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Employees: 37
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
30% more funds holding
Funds holding: 10 [Q3] → 13 (+3) [Q4]
4% more capital invested
Capital invested by funds: $188K [Q3] → $196K (+$7.62K) [Q4]
0.29% more ownership
Funds ownership: 0.75% [Q3] → 1.04% (+0.29%) [Q4]
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Research analyst outlook
We haven’t received any recent analyst ratings for IINN.
Financial journalist opinion
Based on 9 articles about IINN published over the past 30 days









